000			01934 a2200517 4500
005			20250518045336.0
264		0	_c20191230
008			201912s 0 0 eng d
022			_a1873-3476
024	7		_a10.1016/j.ijpharm.2019.118458 _2doi
040			_aNLM _beng _cNLM
100	1		_aNagai, Nobuhiro
245	0	0	_aTransscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. _h[electronic resource]
260			_bInternational journal of pharmaceutics _cAug 2019
300			_a118458 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aChitosan _xadministration & dosage
650	0	4	_aChoroidal Neovascularization _xdrug therapy
650	0	4	_aCollagen _xadministration & dosage
650	0	4	_aDrug Implants _xadministration & dosage
650	0	4	_aDrug Liberation
650	0	4	_aEye _xdrug effects
650	0	4	_aFluorescein-5-isothiocyanate _xadministration & dosage
650	0	4	_aGelatin _xadministration & dosage
650	0	4	_aLasers
650	0	4	_aMale
650	0	4	_aMethacrylates _xadministration & dosage
650	0	4	_aPolyethylene Glycols _xadministration & dosage
650	0	4	_aRanibizumab _xadministration & dosage
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSerum Albumin _xadministration & dosage
700	1		_aNezhad, Zhaleh Kashkouli
700	1		_aDaigaku, Reiko
700	1		_aSaijo, Saaya
700	1		_aSong, Yuanhui
700	1		_aTerata, Keiko
700	1		_aHoshi, Ayako
700	1		_aNishizawa, Matsuhiko
700	1		_aNakazawa, Toru
700	1		_aKaji, Hirokazu
700	1		_aAbe, Toshiaki
773	0		_tInternational journal of pharmaceutics _gvol. 567 _gp. 118458
856	4	0	_uhttps://doi.org/10.1016/j.ijpharm.2019.118458 _zAvailable from publisher's website
999			_c29843851 _d29843851